MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysfunction from compensation to decompensation by targeting Pdx-1.
Wei J, Ding D, Wang T, Liu Q, Lin Y.
Wei J, et al.
FASEB J. 2017 Dec;31(12):5184-5195. doi: 10.1096/fj.201700282R. Epub 2017 Aug 3.
FASEB J. 2017.
PMID: 28774890
The Gpr30/Glp1r-miR-338-Pdx1 axis should be represented as a novel mechanism by which BPA induces insulin secretory dysfunction in pancreatic islets.-Wei, J., Ding, D., Wang, T., Liu, Q., Lin, Y. MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysf …
The Gpr30/Glp1r-miR-338-Pdx1 axis should be represented as a novel mechanism by which BPA induces insulin secretory dysfunction in pancreati …